Hepatocellular carcinoma risk factors
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma risk factors |
|
Risk calculators and risk factors for Hepatocellular carcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2] Mohamad Alkateb, MBBCh [3]
Overview
Common risk factors in the development of hepatocellular carcinoma are chronic hepatitis B infection, chronic hepatitis C infection, cirrhosis, inherited metabolic diseases and aflaoxins.
Common Risk Factors
Common risk factors that may increase the risk of developing hepatocellular carcinoma are:[1][2][3][4][5]
- Chronic hepatitis B
- Chronic hepatitis C
- Cirrhosis with hemochromatosis
- Nonalcoholic steatohepatitis
- Food icontaminated with Aspergillus flavus (especially peanuts and corns stored during prolonged wet seasons), which produces aflatoxins.
Less Common Risk Factors
Less common risk factors that may increase the risk of developing hepatocellular carcinoma are:[6][7][8]
- Anabolic steroids
- Alpha1-antitrypsin deficiency
- Arsenic
- Alcohol
- Obesity
- Diabetes Mellitus
- Food infected with Aspergillus flavus (especially peanuts and corns stored during prolonged wet seasons), which produces aflatoxin.
- Glycogen storage diseases
- Hemochromatosis
- Inherited metabolic diseases such as:
- Smoking
- Tyrosinemia
- Vinyl chloride and thorium dioxide
- Wilson disease
References
- ↑ National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq
- ↑ Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E (2011). "Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study". J. Natl. Cancer Inst. 103 (22): 1686–95. doi:10.1093/jnci/djr395. PMC 3216968. PMID 22021666.
- ↑ Cecil, Russell L., James B. Wyngaarden, and Lloyd H. Smith. Textbook of . Philadelphia: Saunders, 1988. Print.
- ↑ "Redirecting".
- ↑ CHEDID, Marcio F.; KRUEL, Cleber R. P.; PINTO, Marcelo A.; GREZZANA-FILHO, Tomaz J. M.; LEIPNITZ, Ian; KRUEL, Cleber D. P.; SCAFFARO, Leandro A.; CHEDID, Aljamir D. (2017). "HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT". ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 30 (4): 272–278. doi:10.1590/0102-6720201700040011. ISSN 2317-6326.
- ↑ Clavière C, Bronowicki JP, Hudziak H, Bigard MA, Gaucher P (1998). "[Role of sex steroids and their receptors in the pathophysiology of hepatocellular carcinoma]". Gastroenterol. Clin. Biol. (in French). 22 (1): 73–86. PMID 9762169.
- ↑ "Studies of Cancer in Humans - Tobacco Smoke and Involuntary Smoking - NCBI Bookshelf".
- ↑ "Tobacco smoke and involuntary smoking". IARC Monogr Eval Carcinog Risks Hum. 83: 1–1438. 2004. PMC 4781536. PMID 15285078.